跳至主要内容
临床试验/EUCTR2015-000751-25-FI
EUCTR2015-000751-25-FI进行中(未招募)1 期

ZOLEDRONIC ACID, A LONG-ACTING BISPHOSPHONATE, FOR CHRONIC LOW BACK PAIN DUE TO MODIC CHANGES: A RANDOMIZED CONTROLLED TRIAL - ZAMOD

Jaro Karppinen0 个研究点目标入组 250 人开始时间: 2015年12月8日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Low back pain lasting at least 3 months
  • Disabling low back pain (intensity at least 6 on a 0-10 scale or disability on Oswestry Disability Index at least 30%)
  • An inflammatory Modic change on MRI
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 250
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Red flags, recents spine surgery, severe renal impairment

研究者

发起方
Jaro Karppinen

相似试验